Gilead Sciences’ $7.25 Billion Senior Unsecured Notes Offering

Latham & Watkins LLP represented the underwriters, while Davis Polk advised Gilead Sciences in the offering.

Gilead Sciences, Inc. has announced the pricing of senior unsecured notes in an aggregate principal amount of US$7.25 billion, in an underwritten, registered public offering, consisting of seven tranches. The offering is expected to close September 30, 2020, subject to customary closing conditions.

Barclays Capital Inc., Wells Fargo Securities, LLC, Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, HSBC Securities (USA) Inc., J.P. Morgan Securities LLC, RBC Capital Markets, LLC, SG Americas Securities, LLC, SMBC Nikko Securities America, Inc., U.S. Bancorp Investments, Inc., Academy Securities, Inc., and Siebert Williams Shank & Co., LLC acted as underwriters for the offering.

Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.

Latham & Watkins LLP represented the underwriters in the offering with a capital markets team led by New York partner Greg Rodgers (Picture) and Orange County partner Shayne Kennedy, with New York associates Taylor Stevens and Patrick Maguire. Advice was also provided on finance matters by New York partner Melissa Alwang, with New York associates Joseph Zenruffinen and Angelika Ishkhanyan; on tax matters by New York partner Bora Bozkurt, with New York associate Michael Yu; on intellectual property matters by New York partner Alan Tamarelli; on FDA regulatory matters by Washington, D.C. counsel Carolyne Hathaway, with San Diego/Washington, D.C. associate Amy Speros and New York associate Lacey Henry; on healthcare regulatory matters by Bay Area counsel Betty Pang; and on OFAC/AML matters by Washington, D.C. partner Eric Volkman, with Washington, D.C. associate Jason Despain.

Davis Polk advised Gilead Sciences with partners Richard D. Truesdell Jr. and Roshni Banker Cariello and associates Arisa Akashi and Paulina Gordon. Partner Michael Mollerus and associate Alexander J. Hendin provided tax advice. Partner David R. Bauer and associates Tilak Koilvaram and Brette L. Trost provided intellectual property advice. Associate J. Taylor Arabian provided 1940 Act advice.

Involved fees earner: Arisa Akashi – Davis Polk & Wardwell; Taylor Arabian – Davis Polk & Wardwell; Roshni Banker Cariello – Davis Polk & Wardwell; David Bauer – Davis Polk & Wardwell; Paulina Gordon – Davis Polk & Wardwell; Alexander Hendin – Davis Polk & Wardwell; Tilak Koilvaram – Davis Polk & Wardwell; Michael Mollerus – Davis Polk & Wardwell; Brette Trost – Davis Polk & Wardwell; Richard Truesdell Jr. – Davis Polk & Wardwell; Melissa Alwang – Latham & Watkins; Bora Bozkurt – Latham & Watkins; Jason Despain – Latham & Watkins; Carolyne Hathaway – Latham & Watkins; Lacey Henry – Latham & Watkins; Shayne Kennedy – Latham & Watkins; Patrick Maguire – Latham & Watkins; Betty Pang – Latham & Watkins; Gregory Rodgers – Latham & Watkins; Amy Speros – Latham & Watkins; Taylor Stevens – Latham & Watkins; Alan Tamarelli Jr. – Latham & Watkins; Eric Volkman – Latham & Watkins; Michael Yu – Latham & Watkins; Joseph Zenruffinen – Latham & Watkins;

Law Firms: Davis Polk & Wardwell; Latham & Watkins;

Clients: Academy Securities; Barclays Capital ; Citigroup Global Markets Ltd; Gilead Sciences; Goldman Sachs & Co.; HSBC Securities; J.P. Morgan Securities LLC; Mizuho Securities; Morgan Stanley; RBC Capital Markets; SG Americas Securities LLC; Siebert Williams Shank & Co. LLC; SMBC Nikko Securities America; U.S. Bancorp Investments; Wells Fargo Securities;

Author: Ambrogio Visconti